Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently $5.70B. The company's EPS TTM is $0.069655656; its P/E ratio is 8.44; and it has a dividend yield of 7.89%. Guangzhou Baiyunshan Pharmaceutical Holdings Company is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
